.With a trio of biotechs attacking the Nasdaq on Friday, it was quick and easy to miss a smaller-sca...
.Invulnerable checkpoint preventions are the superheroes of cancer treatment. Medications like Brist...
.Accept to recently's Chutes & Ladders, our roundup of substantial management hirings, firings an...
.Regeneron is actually back with lasting follow-up for its own LAG-3 inhibitor as well as PD-1 inhib...
.AstraZeneca has shared a very early consider the efficiency of its own internal antibody-drug conju...
.After announcing a period 3 launch based on good midstage outcomes, iTeos as well as GSK are lastly...
.The FDA should be extra available and also joint to unleash a rise in approvals of uncommon disease...
.It's an uncommonly occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapies...
.Atea Pharmaceuticals' antiviral has fallen short another COVID-19 trial, however the biotech still ...
.Neurocrine Biosciences' schizophrenia system pivot has actually failed. The biotech was unable to i...